Award
Delivery Order #SPE2DR26FMKA3
Short-Term Delivery Order for Midazolam Hydrochloride to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$79.46
Ceiling
$79.46
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26FMKA3
NAICS
424210
This contract is a short-term delivery order awarded under an existing indefinite delivery vehicle (IDV) contract to DMS Pharmaceutical Group Inc., a specialized provider of pharmaceutical products. The specific procurement involves Midazolam Hydrochloride, a medication typically used for sedation and anesthesia purposes. The delivery order supports the agency's ongoing pharmaceutical supply needs, allowing for timely acquisition of essential medications. This contract reflects a continuation of the agency's broader pharmaceutical services agreement with DMS Pharmaceutical Group, which was established through a competitive bidding process to ensure procurement efficiency and reliability. The scope encompasses prompt delivery of the specified pharmaceutical product within a concise two-day performance window. The award benefits the agency's healthcare programs by maintaining critical medicine availability, highlighting a focused and responsive supply chain strategy.
Description
4571187807! MIDAZOLAM HYDROCHLORI